Original Article
Copyright ©2010 Baishideng.
World J Gastroenterol. May 28, 2010; 16(20): 2504-2519
Published online May 28, 2010. doi: 10.3748/wjg.v16.i20.2504
Table 6 Associations between clinicopathological parameters and recurrence risk in patients with extranodal FDC sarcoma
Pathologic parametersRecurrence frequencies (%)P values
Age (yr)
< 5026/51 (51)0.072
≥ 5011/35 (31)
Gender
Male15/40 (38)0.290
Female22/46 (48)
Size (cm)
< 54/25 (16)0.003
≥ 519/34 (56)
Histological grades
Low12/37 (32)0.046
High15/26 (58)
Mitotic counts
< 5/10 HPF8/30 (27)0.013
≥ 5/10 HPF18/31 (58)
Ki-67-LI
< 10%2/6 (25)0.628
≥ 10%8/14 (57)
Necrosis
Absent17/35 (49)0.307
Present13/29 (45)
Treatments
Surgery alone22/52 (42)0.590
Surgery + adjuvant therapy15/31 (48)
Sites
Abdominal/pelvic18/37 (49)0.372
Other sites20/53 (38)